Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
By Drug Type, Liraglutide Segment Accounts for 35.5% Market Share The liraglutide segment is projected to account for 35.5% of the GLP-1 diabetes treatment drugs market in 2025, reaffirming its position as the leading drug type category
Other experts too agreed that in Indias context, the new evidence raises important questions
Many patients report reduced appetite within the first 24 weeks
You can also check savings programs offered by the manufacturers (Novo Nordisk and Eli Lilly) to see if you qualify for assistance
Tirzepatide and semaglutide have become household names, mostly thanks to their effectiveness in body weight reduction
US$ 26.37
US$ 27.61
US$ 22.92
US$ 28.00
US$ 27.66
US$ 22.80
